The financial world was buzzing in August when Teladoc (NYSE: TDOC) purchased Livongo Health for an eye-popping $18.5 billion. While both companies were thriving -- Livongo was more than doubling sales every year, and Teladoc was also growing fast and increasing its network of members and providers -- some investors worried that this was far too high a price for an acquisition at the height of a once-in-a-century pandemic. To many, it seemed that neither company should have wanted to do the deal at the time. The next month, Amwell (NYSE: AMWL) went public with a $100 million injection from Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) , and remote health was back on everyone's mind.
Through all of this, one company that's been overlooked in this space has been signaling its intention to be a leader in telemedicine. If history is any indication, Zoom Technology (NASDAQ: ZM) will be the stock to own in virtual care.
Image source: Getty Images
For further details see:
Forget Livongo: This Is a Better Telehealth Stock